Skip to main content

Table 1 Sample sizes of 13 tumor types before and after filtering to ensure sufficient mutations per sample and total samples.

From: Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes

Cancera,b

Sample size

Full

(# mutations ≥ 6)

FoundationOne

(# mutations ≥ 1)

PanCan

(# mutations ≥ 1)

TrueSeq

(# mutations ≥1)

BLCA

99

99 (100%)

97(98%)

95 (96%)

84 (85%)

BRCA

887

849 (96%)

661 (75%)

647 (73%)

528 (60%)

CRC

233

233 (100%)

227 (97%)

226 (97%)

219 (94%)

ESO

140

140 (100%)

133 (95%)

125 (89%)

112 (80%)

GBM

291

288 (99%)

247 (85%)

237 (81%)

199 (68%)

HNSC

384

372 (97%)

357 (93%)

347 (90%)

303 (79%)

KIRC

417

414 (99%)

328 (79%)

310 (74%)

220 (53%)

LUAD

398

391 (98%)

372 (93%)

359 (90%)

322 (81%)

LUSC

176

176 (100%)

176 (100%)

175 (99%)

158 (90%)

MEL

118

118 (100%)

117 (99%)

113 (96%)

112 (95%)

MM

204

200 (98%)

157 (77%)

146 (72%)

121(59%)

OV

316

313 (99%)

276 (87%)

281 (89%)

238 (75%)

UCEC

247

247 (100%)

245 (%99)

242 (98%)

229 (93%)

Total

4143

4008

   
  1. aBLCA-Bladder urothelial carcinoma; BRCA-Breast invasive carcinoma; CRC-Colorectal carcinoma; ESO-Esophageal adenocarcinoma; GBM-Glioblastoma multiforme; HNSC-Head and neck squamous cell carcinoma; KIRC-Kidney renal clear cell carcinoma; LUAD-Lung adenocarcinoma; LUSC-Lung squamous cell carcinoma; MEL-Melanoma; MM-Multiple myeloma; OV-Ovarian serous cystadenocarcinoma; UCEC-Uterine corpus endometrial carcinoma
  2. bCancer types with survival data: BLCA, BRCA, CRC, ESO, GBM, HNSC, KIRC, LUAD, LUSC, OV,UCEC.